Skip to content

ATOSSA THERAPEUTICS, INC.: 10-Q filed 2013-11-12

What ATOSSA THERAPEUTICS, INC. reported in its quarterly report filed 2013-11-12 (fiscal Q3 2013): 34 published measures, 108 facts as tagged in accession 0001144204-13-060511.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-12
Fiscal period
fiscal Q3 2013
Accession
0001144204-13-060511 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3013,482,221USD
At 2012-12-316,826,133USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-3011,539,949USD
At 2012-12-315,175,535USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-307,693,561USD
At 2012-12-311,725,197USD
At 2012-09-30418,570USD
At 2011-12-311,910,821USD
At 2009-04-290USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-3,501,845USD92
2013-01-01 to 2013-09-30-8,026,984USD273
2009-04-30 to 2013-09-30-17,758,892USD1615
2012-07-01 to 2012-09-30-1,143,382USD92
2012-01-01 to 2012-09-30-3,374,249USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-6,182,060USD273
2009-04-30 to 2013-09-30-14,007,675USD1615
2012-01-01 to 2012-09-30-1,967,626USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-3012,551,098USD273
2009-04-30 to 2013-09-3022,373,423USD1615
2012-01-01 to 2012-09-30475,375USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-400,674USD273
2009-04-30 to 2013-09-30-672,187USD1615
2012-01-01 to 2012-09-300USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-17,758,892USD
At 2012-12-31-9,731,906USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-300USD92
2013-01-01 to 2013-09-300USD273
2009-04-30 to 2013-09-30250USD1615
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-30443,272USD
At 2012-12-31159,967USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,187,717USD273
2009-04-30 to 2013-09-301,479,981USD1615
2012-01-01 to 2012-09-3096,251USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-3,501,897USD92
2013-01-01 to 2013-09-30-8,026,677USD273
2009-04-30 to 2013-09-30-17,725,752USD1615
2012-07-01 to 2012-09-30-1,135,672USD92
2012-01-01 to 2012-09-30-3,363,652USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-308,595,445USD
At 2012-12-311,989,495USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-301USD92
2013-01-01 to 2013-09-30360USD273
2009-04-30 to 2013-09-3039,531USD1615
2012-07-01 to 2012-09-307,756USD92
2012-01-01 to 2012-09-3011,816USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-301,942,272USD
At 2012-12-311,650,598USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-3031,131USD
At 2012-12-3168,217USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-09-304,407,058USD
At 2012-12-314,640,224USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-30299,338USD
At 2012-12-31141,665USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-303,552,556USD92
2013-01-01 to 2013-09-308,297,460USD273
2009-04-30 to 2013-09-3018,317,058USD1615
2012-07-01 to 2012-09-301,226,171USD92
2012-01-01 to 2012-09-303,687,169USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-3050,659USD92
2013-01-01 to 2013-09-30270,783USD273
2009-04-30 to 2013-09-30591,306USD1615
2012-07-01 to 2012-09-3090,499USD92
2012-01-01 to 2012-09-30323,517USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-07-01 to 2013-09-3025,938USD92
2013-01-01 to 2013-09-30314,562USD273
2009-04-30 to 2013-09-30355,471USD1615
2012-07-01 to 2012-09-309,000USD92
2012-01-01 to 2012-09-3029,985USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-30321,111USD92
2013-01-01 to 2013-09-30731,258USD273
2009-04-30 to 2013-09-304,288,644USD1615
2012-07-01 to 2012-09-30548,108USD92
2012-01-01 to 2012-09-301,508,944USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3017,444,824shares
At 2012-12-3112,919,367shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3029,281,396USD
At 2012-12-3114,894,522USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-3093,930USD
At 2012-12-3131,081USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-304,443,504USD
At 2012-12-314,676,671USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-8,026,984USD273
2009-04-30 to 2013-09-30-17,758,892USD1615
2012-01-01 to 2012-09-30-3,374,249USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-302,858,027USD92
2013-01-01 to 2013-09-306,600,819USD273
2009-04-30 to 2013-09-3012,423,155USD1615
2012-07-01 to 2012-09-30590,359USD92
2012-01-01 to 2012-09-301,896,254USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-09-3062,849USD273
2012-01-01 to 2012-09-3012,970USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-30350,536USD273
2009-04-30 to 2013-09-30496,711USD1615
2012-01-01 to 2012-09-3025,586USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2013-01-01 to 2013-09-300USD273
2009-04-30 to 2013-09-30250USD1615
2012-01-01 to 2012-09-300USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30386,514USD273
2009-04-30 to 2013-09-30528,179USD1615
2012-01-01 to 2012-09-30174,183USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-300USD273
2009-04-30 to 2013-09-30121,910USD1615
2012-01-01 to 2012-09-3029,884USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-37,086USD273
2009-04-30 to 2013-09-3031,131USD1615
2012-01-01 to 2012-09-307,335USD274

Inspect the source

Entity
ATOSSA THERAPEUTICS, INC. / CIK 0001488039
Captured
2026-09-20T09:09:43.864Z
SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))